CVS Sale Of Omnicare Long-Term Care Pharmacy Continues Portfolio Revamp
The post CVS Sale Of Omnicare Long-Term Care Pharmacy Continues Portfolio Revamp appeared on BitcoinEthereumNews.com. In this photo is CVS Health Corp. signage on the floor of the New York Stock Exchange (NYSE) in New York, US, on Monday, July 28, 2025. Photographer: Michael Nagle/Bloomberg © 2025 Bloomberg Finance LP A bankruptcy court has approved the sale of CVS Health’s underperforming Omnicare long-term care pharmacy network to GenieRx in a deal valued at $250 million. CVS said the sale to GenieRx followed a “comprehensive sale process” that was approved by the U.S. Bankruptcy Court for the Northern District of Texas. GenieRx, a joint partnership between private investment firm Milrose Capital LLC and health-care investment and management firm Integro Healthcare Services, “will have the opportunity to strengthen” Omnicare’s service, CVS said. For CVS, the deal is the latest to focus on profitable businesses. The company’s Aetna health insurance unit left the business of selling in